Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chairman and CEO, Director
-
Stock Symbol
-
ITCI on Nasdaq
Sharon Mates - trading volume in the past year for Intra-Cellular Therapies, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
1.07M |
$78.5M |
$73.32 |
Aug 30, 2024 |
Direct |
|
|
Restricted Stock Units |
20.6K |
$1.38M |
$67.12 |
Mar 10, 2024 |
Direct |
Common Stock |
|
Stock Option (right to buy) |
103K |
|
|
Aug 30, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.